Paths of Progress 2016
A selection of articles from the 2016 issue of Paths of Progress.
A promising new class of cancer drugs is emerging after nearly three decades of research.
Bringing new understanding and innovative therapies to esophageal and gastric cancers.
A closer look at aspirin and other common medicine cabinet compounds that may yet hold vital keys to preventing some cancers.
A retrospective look at the visionary leadership of outgoing Dana-Farber President and CEO Edward J. Benz Jr., MD.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.
The Media Team cannot respond to patient inquiries. For more information on contacting Dana-Farber, please see Contact Us.